| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/19/2013 | CN103167870A Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues |
| 06/19/2013 | CN103167867A Solid dispersions containing an apoptosis-inducing agent |
| 06/19/2013 | CN103167862A Use of monoamine oxidase inhibitors to improve epithelial biology |
| 06/19/2013 | CN103167802A Anti-microbial compositions |
| 06/19/2013 | CN103167800A Ready to use ketorolac formulations |
| 06/19/2013 | CN103167799A Synergistic fungicidal and algicidal compositions including 2-hydroxyphenylaldehyde and 2-hydroxyphenylketone heterocycloylhydrazones and copper |
| 06/19/2013 | CN103160557A Purpose of ribosomal protein S5 in catalyzing of protein molecules for generatation of dephosphorylation reaction |
| 06/19/2013 | CN103159835A Lys and oligopeptide-modified curcumin derivatives, and synthesis and medical application thereof |
| 06/19/2013 | CN103159826A Lys and Lys (Pro-Ala-Lys)-modified curcumin derivatives, and synthesis and medical application thereof |
| 06/19/2013 | CN103159821A Lanostane triterpenoid and application thereof |
| 06/19/2013 | CN103159815A Monophosphate vidarabine crystalline compound, medical composition and preparation method thereof |
| 06/19/2013 | CN103159814A Gambogic acid ester derivative as well as preparation method and use thereof |
| 06/19/2013 | CN103159801A N-ferrocenyl-N'-aryl urea compound and applications thereof |
| 06/19/2013 | CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier |
| 06/19/2013 | CN103159787A Preparation method for high-purity sterilized cefotiam hydrochloride and pharmaceutical composition containing cefotiam hydrochloride |
| 06/19/2013 | CN103159786A Preparation method for high-purity sterilized cefmenoxime hydrochloride and pharmaceutical composition containing cefmenoxime hydrochloride |
| 06/19/2013 | CN103159785A Cefuroxime lysine and preparation thereof |
| 06/19/2013 | CN103159784A Cefuroxime lysine and preparation thereof |
| 06/19/2013 | CN103159774A Extraction, separation and purification method for strychnos total alkaloid |
| 06/19/2013 | CN103159770A Crystal form of ertapenem monosodium salt |
| 06/19/2013 | CN103159769A Doxofylline compound and medicine composition thereof |
| 06/19/2013 | CN103159760A Azaindole derivatives as cftr modulators |
| 06/19/2013 | CN103159758A (1S,3S)-1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline acyl amino acid, and synthesis, antithrombotic activity and application as antithrombotic agent thereof |
| 06/19/2013 | CN103159755A Alpha-glycosidase inhibitor preparation method and purpose |
| 06/19/2013 | CN103159754A Amino propyl replacing tropane amine compound, medical composition thereof, preparation method and purpose thereof |
| 06/19/2013 | CN103159748A Preparation and application of 2-(1H-1, 2, 3-triazole-4-group) aniline compounds |
| 06/19/2013 | CN103159742A 5-Chloropyrimidine compound and application of 5-Chloropyrimidine compound serving as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor |
| 06/19/2013 | CN103159741A Preparation and application of novel tyrosine kinase inhibitor |
| 06/19/2013 | CN103159740A Preparation and application of 1, 5-distributed-1, 2, 3-triazole trifluoromethyl type compound |
| 06/19/2013 | CN103159739A 1, 4-disubstituted-1, 2, 3-triazole compounds and preparation method thereof |
| 06/19/2013 | CN103159738A Mixed aromatic compound of alkynyl bridging and application thereof |
| 06/19/2013 | CN103159737A Esomeprazole sodium compound and medicine composition |
| 06/19/2013 | CN103159736A Substitutional pyrazol kinase inhibitor |
| 06/19/2013 | CN103159735A Substitutional imidazole kinase inhibitor |
| 06/19/2013 | CN103159733A Thiophene methanamide compound with NDM-1 inhibitory activity |
| 06/19/2013 | CN103159732A Polyacetylene compound, extract containing same and application of polyacetylene compound |
| 06/19/2013 | CN103159729A Alpha-, gamma-mangostin derivative and application in anti-cancer drug preparation thereof |
| 06/19/2013 | CN103159726A Chromene ketone derivative used as transient receptor potential vanillin3 (TRPV3) antagonist |
| 06/19/2013 | CN103159721A 8-epi-12-epi-isoandrographolidume-19-sulfate, preparation method and purposes of prepared medicine |
| 06/19/2013 | CN103159720A 8-epi-isoandrographolidume-19-sulfate, preparation method and purposes of prepared medicine |
| 06/19/2013 | CN103159717A 17-hydrogen-9-dehydro-andrographolidume-3, 19-disulfate, preparation method and purposes of medicine prepared by the same |
| 06/19/2013 | CN103159716A 17-hydrogen-9-dehydro-andrographolidume-3-disulfate, preparation method and purposes of prepared medicine |
| 06/19/2013 | CN103159715A 17-hydrogen-9-dehydro-andrographolidume-14-sulfate, preparation method and purposes of medicine prepared by the same |
| 06/19/2013 | CN103159714A 17-hydrogen-9-dehydro-andrographolidume-19-sulfate, preparation method and purposes of medicine prepared by the same |
| 06/19/2013 | CN103159713A Composite of 17-hydrogen-9-dehydro-andrographolidume-3, 19-sodium (or potassium) disulfate and 17-hydrogen-9-dehydro-andrographolidume-19-sodium (or potassium) disulfate, and purposes of medicine prepared by the same |
| 06/19/2013 | CN103159712A Compound of 17-hydrogen-9-dehydrogenation andrographolide-3-sulphate sodium (or potassium) and 17-hydrogen-9-dehydrogenation andrographolide-3, 19-disulfate sodium (or potassium) and preparation drug purposes thereof |
| 06/19/2013 | CN103159711A Once preparation method of composite of 17-hydrogen-9-dehydro-andrographolidume-3, 19-sodium (or potassium) disulfate and 17-hydrogen-9-dehydro-andrographolidume-19-sodium (or potassium) disulfate, and purposes of prepared medicine |
| 06/19/2013 | CN103159710A Antiviral decalin derivate |
| 06/19/2013 | CN103159709A Potassium dehydroandrograpolide succinate crystal and preparation method thereof |
| 06/19/2013 | CN103159708A Once preparation method of composite of 17-hydrogen-9-dehydro-andrographolidume-3-sodium (or potassium) disulfate and 17-hydrogen-9-dehydro-andrographolidume-19-sodium (or potassium) disulfate, and purposes of medicine prepared by the same |
| 06/19/2013 | CN103159695A Thiazole compound capable of restraining human immunodeficiency virus (HIV) replication and effective against drug-resistant HIV virus strains and preparation method and purpose thereof |
| 06/19/2013 | CN103159692A Tetrazole-substituted arylamides |
| 06/19/2013 | CN103159691A Preparing method and application of isothiocyanate compound |
| 06/19/2013 | CN103159690A Crystallization form of symmetric macrocyclic amine compound |
| 06/19/2013 | CN103159686A HIV-1 protease urea inhibitor |
| 06/19/2013 | CN103159680A Imidazole diketone compound and application thereof |
| 06/19/2013 | CN103159674A 2-benzene alkyl amid compound and preparation method, medical composition and use thereof |
| 06/19/2013 | CN103159668A 2-hydroxy-4-oxo-2-butenoic acid compound and pharmaceutical application thereof |
| 06/19/2013 | CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof |
| 06/19/2013 | CN103159666A Isatin derivative and purpose thereof |
| 06/19/2013 | CN103159665A Isatin-5-amide inhibiting agent with inhibition effect against SARS coronavirus main protease |
| 06/19/2013 | CN103159664A Silodosin bulk drug as well as preparation method and medicine composition thereof |
| 06/19/2013 | CN103159660A (2R)-1-(2-methyl-3-(methoxy(methyl)amino)-propionyl)pyrrolidine-2-carboxylic acid and application thereof |
| 06/19/2013 | CN103159652A Preparation and application of sulfonamide compound |
| 06/19/2013 | CN103159651A Sulfonylurea guanidine and preparation method and application thereof |
| 06/19/2013 | CN103159650A Preparation and application of aromatic heterocyclic sulfonamide compound |
| 06/19/2013 | CN103159649A Preparation of sulfonamides compounds and application of sulfonamides compounds |
| 06/19/2013 | CN103159646A Hydroxamic acid compound, and preparation method and application thereof |
| 06/19/2013 | CN103159644A Curcuminoid condensed aromatic amine Schiff base derivative, as well as preparation method and application thereof in preparation of antibacterial medicaments |
| 06/19/2013 | CN103159636A Aminomethyl caproic acid derivative and use |
| 06/19/2013 | CN103159618A 4-carbonyl-2-butene acid compound and purpose thereof |
| 06/19/2013 | CN103158941A Method for improving light stability of fasudil or its salt injection liquid |
| 06/19/2013 | CN103157117A Medicine for regulating and controlling TRAIL (Tnf (Tumor necrosis factor) Related Apoptosis Inducing Ligand) tolerance of tumour |
| 06/19/2013 | CN103157112A Application of sialic acid derivatives in preparation of polyethylene glycol (PEG) lipid derivative modifying agent |
| 06/19/2013 | CN103157111A New combinaition and pharmaceutical compositions containing same |
| 06/19/2013 | CN103157110A Application of aromatase inhibitor in preparation of anti-cirrhosis or anti-liver fibrosis drugs |
| 06/19/2013 | CN103157108A An immunomodulator composition, and a pharmaceutical composition and applications thereof |
| 06/19/2013 | CN103157099A Mixed enzyme digestive juice for fast digestion of vascular adventitia and preparation method thereof |
| 06/19/2013 | CN103157095A Kidney bean phytolectin applications in preparation of human drugs and drug composition thereof |
| 06/19/2013 | CN103157094A Pantoprazole sodium medicine composition for injection and preparation method thereof |
| 06/19/2013 | CN103157060A Pure traditional Chinese medicine composition having effects of dredging meridian and activating collaterals, as well as promoting qi circulation and eliminating blood stasis, and preparation method for same |
| 06/19/2013 | CN103157052A Lotion for treating gynecological inflammation |
| 06/19/2013 | CN103157026A Ginseng pill |
| 06/19/2013 | CN103157025A Qi tonifying and yang elevating pill |
| 06/19/2013 | CN103157018A Solvent used for treating Parkinson's disease |
| 06/19/2013 | CN103157015A Pill for recovery from muscle and bone inflammation |
| 06/19/2013 | CN103156994A Throat protection pill |
| 06/19/2013 | CN103156988A Dispersible tablet for clearing heat, relieving sore-throat, detoxifying and relieving pain, and preparation method for same |
| 06/19/2013 | CN103156972A Traditional Chinese medicine combination for treating fracture, hairline fracture and traumatic injury |
| 06/19/2013 | CN103156967A Medicine liquid used for treating dementia |
| 06/19/2013 | CN103156954A Antiphlogistic and anti-allergy pill |
| 06/19/2013 | CN103156953A Blood circulation smoothing pill |
| 06/19/2013 | CN103156939A External compound preparation for treating hemorrhoids |
| 06/19/2013 | CN103156929A 脑瘫康丸 Cerebral palsy Pill |
| 06/19/2013 | CN103156926A Drug composition for treating diarrhea and preparation method thereof |
| 06/19/2013 | CN103156919A Capsule for treating liver injury and preparation method for same |
| 06/19/2013 | CN103156917A Preparation method of Sanhua bone setting powder |
| 06/19/2013 | CN103156916A Pharmaceutical composition for treating heart disease |
| 06/19/2013 | CN103156912A Pill for removing cold arthralgia of muscles and bones |
| 06/19/2013 | CN103156911A Blood circulation smoothing paste |